Literature DB >> 10487565

Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors.

V S Khoo1, M Oldham, E J Adams, J L Bedford, S Webb, M Brada.   

Abstract

PURPOSE: Intensity-modulated radiotherapy (IMRT) offers the potential to more closely conform dose distributions to the target, and spare organs at risk (OAR). Its clinical value is still being defined. The present study aims to compare IMRT with stereotactically guided conformal radiotherapy (SCRT) for patients with medium size convex-shaped brain tumors. METHODS AND MATERIALS: Five patients planned with SCRT were replanned with the IMRT-tomotherapy method using the Peacock system (Nomos Corporation). The planning target volume (PTV) and relevant OAR were assessed, and compared relative to SCRT plans using dose statistics, dose-volume histograms (DVH), and the Radiation Therapy Oncology Group (RTOG) stereotactic radiosurgery criteria.
RESULTS: The median and mean PTV were 78 cm3 and 85 cm3 respectively (range 62-119 cm3). The differences in PTV doses for the whole group (Peacock-SCRT +/-1 SD) were 2%+/-1.8 (minimum PTV), and 0.1%+/-1.9 (maximum PTV). The PTV homogeneity achieved by Peacock was 12.1%+/-1.7 compared to 13.9%+/-1.3 with SCRT. Using RTOG guidelines, Peacock plans provided acceptable PTV coverage for all 5/5 plans compared to minor coverage deviations in 4/5 SCRT plans; acceptable homogeneity index for both plans (Peacock = 1.1 vs. SCRT = 1.2); and comparable conformity index (1.4 each). As a consequence of the transaxial method of arc delivery, the optic nerves received mean and maximum doses that were 11.1 to 11.6%, and 10.3 to 15.2% higher respectively with Peacock plan. The maximum optic lens, and brainstem dose were 3.1 to 4.8% higher, and 0.6% lower respectively with Peacock plan. However, all doses remained below the tolerance threshold (5 Gy for lens, and 50 Gy for optic nerves) and were clinically acceptable.
CONCLUSIONS: The Peacock method provided improved PTV coverage, albeit small, in this group of convex tumors. Although the OAR doses were higher using the Peacock plans, all doses remained within the clinically defined threshold and were clinically acceptable. Further improvements may be expected using other methods of IMRT planning that do not limit the treatment delivery to transaxial arcs. Each IMRT system needs to be individually assessed as the paradigm utilized may provide different outcomes.

Entities:  

Mesh:

Year:  1999        PMID: 10487565     DOI: 10.1016/s0360-3016(99)00213-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Optic toxicity in radiation treatment of meningioma: a retrospective study in 213 patients.

Authors:  Mostafa Farzin; Michael Molls; Severin Kampfer; Sabrina Astner; Ralf Schneider; Karin Roth; Michaela Dobrei; Stephanie Combs; Christoph Straube
Journal:  J Neurooncol       Date:  2016-02-06       Impact factor: 4.130

Review 2.  Modern techniques for pituitary radiotherapy.

Authors:  G Minniti; D C Gilbert; M Brada
Journal:  Rev Endocr Metab Disord       Date:  2009-06       Impact factor: 6.514

3.  Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

Authors:  Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

Review 4.  18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.

Authors:  Eric C Ford; Joseph Herman; Ellen Yorke; Richard L Wahl
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

Review 5.  Meningioma: current treatment options and future directions.

Authors:  Kevin P McMullen; Volker W Stieber
Journal:  Curr Treat Options Oncol       Date:  2004-12

6.  A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases.

Authors:  George Rodrigues; Slav Yartsev; Keng Yeow Tay; Gregory R Pond; Frank Lagerwaard; Glenn Bauman
Journal:  Radiat Oncol       Date:  2012-03-21       Impact factor: 3.481

7.  Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgery.

Authors:  Anees Dhabaan; Eric Elder; Eduard Schreibmann; Ian Crocker; Walter J Curran; Nelson M Oyesiku; Hui-Kuo Shu; Tim Fox
Journal:  J Appl Clin Med Phys       Date:  2010-06-21       Impact factor: 2.102

8.  Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses.

Authors:  Öznur Şenkesen; Evrim Tezcanlı; Mehmet Ufuk Abacıoğlu; Zeynep Özen; Derya Çöne; Halil Küçücük; Evren Ozan Göksel; Alptekin Arifoğlu; Meriç Şengöz
Journal:  Radiat Oncol J       Date:  2022-03-28

9.  Comparison of stereotactic plans for brain tumors with two different multileaf collimating systems.

Authors:  Livia Marrazzo; Margherita Zani; Stefania Pallotta; Daniela Greto; Silvia Scoccianti; Cinzia Talamonti; Giampaolo Biti; Marta Bucciolini
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

10.  Quality assurance devices for dynamic conformal radiotherapy.

Authors:  Victy Y M Wong
Journal:  J Appl Clin Med Phys       Date:  2004-01-01       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.